Flash FinanceUS
Pre-market S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Scotts Miracle-Gro (SMG)

Scotts Miracle-Gro FY2026 sales rise 1% to $3.29 billion; Q4 operating loss widens

Mixed Impact 3 of 5 earnings

Scotts Miracle-Gro reported results for the fourth quarter and fiscal year ended September 30, 2026, and gave fiscal 2027 guidance. Full-year net sales rose 1% and adjusted EPS from continuing operations rose 18%, but fourth-quarter net sales fell 11% and the operating loss widened, so results point in mixed directions for shareholders.

Key points

  • Fiscal 2026 net sales were $3.29 billion, up 1%; fourth-quarter net sales were $302.9 million, down 11% from $340.1 million.
  • Fiscal 2026 adjusted diluted EPS from continuing operations was $4.48, up 18%; GAAP diluted EPS from continuing operations was $3.30, up 6%.
  • Fourth-quarter loss from operations was $143.0 million, compared with $123.8 million a year earlier.
  • Fiscal 2027 guidance calls for adjusted EPS of $4.70 to $4.90 and free cash flow of approximately $275 million.

The filing

CompanyScotts Miracle-Gro (SMG)
Form8-K, current report
Filed with the SECNov 4, 2026, 7:33 AM ET
Accession number0000825542-26-000061

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI on Nov 7, 2026, 11:17 PM ET, from this filing only.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.